Antibody response after 2 and 3 doses of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic cell transplant recipients
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antibody response after 2 and 3 doses of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic cell transplant recipients
Authors
Keywords
-
Journal
BLOOD
Volume 139, Issue 1, Pages 134-137
Publisher
American Society of Hematology
Online
2021-11-25
DOI
10.1182/blood.2021014232
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy of the BNT162b2 mRNA COVID-19 Vaccine in Patients with Chronic Lymphocytic Leukemia
- (2021) Yair Herishanu et al. BLOOD
- Antibody response to mRNA SARS-CoV-2 vaccine among kidney transplant recipients – Prospective cohort study
- (2021) Benaya Rozen-Zvi et al. CLINICAL MICROBIOLOGY AND INFECTION
- Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients
- (2021) Brian J. Boyarsky et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- WHO International Standard for anti-SARS-CoV-2 immunoglobulin
- (2021) Paul A Kristiansen et al. LANCET
- Efficiency of a boost with a third dose of anti‐SARS‐CoV‐2 messenger RNA‐based vaccines in solid organ transplant recipients
- (2021) Arnaud Del Bello et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses
- (2021) Ilies Benotmane et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Antibody response after second BNT162b2 dose in allogeneic HSCT recipients
- (2021) Rabah Redjoul et al. LANCET
- COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey
- (2021) Per Ljungman et al. LEUKEMIA
- Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients
- (2021) Nassim Kamar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients
- (2021) Victoria G. Hall et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates
- (2021) Kizzmekia S. Corbett et al. SCIENCE
- Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study
- (2021) Kazimieras Maneikis et al. Lancet Haematology
- Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection
- (2021) Shuo Feng et al. NATURE MEDICINE
- Antibody response after third BNT162b2 dose in recipients of allogeneic HSCT
- (2021) Rabah Redjoul et al. Lancet Haematology
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started